SOPHiA GENETICS
Healthcare Software · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
La Piece 12, Rolle, Vaud, 1180, Switzerl...Phone Number
+41 216941060Website
www.sophiagenetics.comRevenue
$64.9 MillionStock Symbol
SOPHIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
3
5
2
2
About SOPHiA GENETICS
SOPHiA GENETICS is a data-driven medicine company that uses statistical inference, pattern recognition and machine learning for genomics and radiomics data to support the healthcare industry. SOPHiA GENETICS, headquartered in Saint-Sulpice, Switzerland, is used by geneticists, pathologists and radiologists in hospitals.Explore more
SOPHiA GENETICS Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SOPHiA GENETICS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at SOPHiA GENETICS
Funding: Get notified immidiatlly once SOPHiA GENETICS has new funding data
Earning: See what the market has to say on SOPHiA GENETICS recently announced quarterly report
Click to see if SOPHiA GENETICS had a recent Job posting/layoffs
Product Launch: Get notified when SOPHiA GENETICS launches new products
SOPHiA GENETICS, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if SOPHiA GENETICS has recently received funding, and reach out quickly before it becomes old news!
Check out if SOPHiA GENETICS is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
SOPHiA GENETICS is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
SOPHiA GENETICS is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about SOPHiA GENETICS.
SOPHiA GENETICS financials insights
Gather financial insights about SOPHiA GENETICS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series A
$3M
2014
Series B
$13.8M
2015
Series C
$15M
2017
Series D
$30M
2019
Series E
$77M
2020
Series F
$110M
2021
Share Placement
$234M
SOPHiA GENETICS Tech Stack
A closer look at the technologies used by SOPHiA GENETICS
Most Recent Scoops
Person-Based
Medical Research, Public Health, Artificial Intelligence
Partnership
SOPHiA GENETICS has announced an expanded partnership with Mount Sinai to bring hemato-oncology and solid tumor testing to the New York market using SOPHiA DDM, joining existing New York area partners NYU Langone Health and Memorial Sloan Kettering Cancer Center.
Partnership
Partnership
SOPHiA GENETICS has signed contracts with major biopharma companies including AstraZeneca and Johnson & Johnson, as well as biotechs including Cartos.
Partnership, Pharmaceuticals, Contracts
Pain Point
SOPHiA GENETICS is facing patent infringement claims filed by Guardant Health in the United Kingdom and at the Unified Patent Court in Paris, alleging that its MSK-ACCESS application infringes Guardant's patents, resulting in approximately CHF 1.4 million in related legal expenses during Q1 2026. The Unified Patent Court rejected Guardant's request for provisional measures and ordered Guardant to pay SOPHiA GENETICS $700,000 in interim costs, of which $500,000 was received in mid-March and an additional $200,000 in mid-April, reducing the net litigation impact on Q1 operating expenses to approximately CHF 700,000.
Intellectual Property, Lawsuits, Legal Affairs, Legal Counsel
Partnership
Partnership
SOPHiA GENETICS News & Media
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
BOSTON and ROLLE, Switzerland, June 19, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced underwritten public offering with total gross proceeds of $57.5 million, before deducting...SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares
BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the pricing of its previously announced underwritten public offering of 10,526,000 ordinary shares at a public offering price of $4....SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares
BOSTON and ROLLE, Switzerland, June 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the commencement of a proposed underwritten public offering of its ordinary shares. The Company also expects to grant the...SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting
Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board BOSTON and ROLLE, Switzerland, June 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today confirmed, ahead of its 2026 Annual General Meeting (AGM) scheduled for June 18, 2026, the leadership changes first announced in January 2026. The Board has appointed Ross Muken, currently
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SOPHiA GENETICS
Sign Up For FreeTo access detailed company insights
SOPHiA GENETICS is a data-driven medicine company that uses statistical inference, pattern recognition and machine learning for genomics and radiomics data to support the healthcare industry. SOPHiA GENETICS, headquartered in Saint-Sulpice, Switzerland, is used by geneticists, pathologists and radiologists in hospitals.... Read More
